放射性核素骨显象诊断乳腺癌骨转移174例分析  

RADIONUCLIDE BONE IMAGING FOR DIAGNOSIS OF SKELETAL METASTASES IN 174 PATIENTS WITH BREAST CANCER

作　　者：郭肖南[1] 梁昌华[1] 彭庆泉 李惠兰[1] 胡立宪[1] 费慧娟[2] 余超仑 

机构地区：[1]湖南医科大学第一附属医院核医学科 [2]湖南医科大学第一附属医院外科

出　　处：《湖南医科大学学报》1989年第2期153-155,共3页Bulletin of Hunan Medical University

摘　　要：174例已确诊的乳腺癌患者行全身放射性核素骨显象检查,发现58例有骨转移,阳性率为33.33％。以躯干骨和骨盆最为多见(89.39％)。单发转移病灶占32.76％,多发转移病灶为67.24％。放射性核素骨显象能在X线检查出现异常前显示骨病变的存在,故定期放射性核素骨显象检查对乳腺癌骨转移的早期诊断、观察疗效和判断预后有重要价值。Whole-body radionuclide bone imaging was performed in 174 patients with breast cancer, giving a positive rate of skeletal metastases 33.33% (58 / 174) .ninety per cent of the skeletal metastases occurred in the trunk and pelvic bone, and 32.76% of skeletal metastases appeared in solitary focus, 67.24% in multiple foci. Radionuclide bone imaging is a sensitive and significant diagnostic method in skeletal metastases.It can be used to detect these lesions earlier than roentgenogram , and hence periodic radionuclide bone imaging is important in the early diagnosis of skeletal metastases, observation of curative effects and judgement of prognosis.

关 键 词：乳腺癌 骨显象 诊断 肿瘤转移 

分 类 号：R730.44[医药卫生—肿瘤]